Patents Assigned to Glo Pharma, Inc.
  • Nicotinic acetylcholine receptor peptide antagonist conotoxin compositions and related methods
    Patent number: 11970552
    Abstract: The present invention relates to novel peptide antagonists that inhibit binding of acetylcholine to the active site of the muscle-type nicotinic acetylcholine receptor. The peptide antagonists of the invention are useful in cosmetic compositions that prevent or improve the appearance of skin wrinkles and related skin conditions. The invention further relates to cosmetic and pharmaceutical compositions comprising a peptide antagonist of the invention, and methods for their use.
    Type: Grant
    Filed: August 23, 2021
    Date of Patent: April 30, 2024
    Assignee: Glo Pharma, Inc.
    Inventor: Robert A. Love